Estradiol/Norethindrone

้›ŒไบŒ้†‡/็‚”่ฏบ้…ฎ

Report date: 2025/11/21 10:15:14

Base Information

Drug NameEstradiol/Norethindrone
Drug Alias Name็‚”่ฏบ้…ฎ/้›ŒไบŒ้†‡Norethisterone/EstradiolEstradiol and Norethindrone้›ŒไบŒ้†‡+็‚”่ฏบ้…ฎ็‚”่ฏบ้…ฎ้›ŒไบŒ้†‡ +[16]ย 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsMenopausal symptomsDysmenorrheaOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsYes EstradiolNorethindrone
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesNobelpharma Co Ltd
Active IndicationsMenopausal symptomsOsteoporosis, Postmenopausal
Inactive IndicationsDysmenorrhea

Other Information

ATC CodeG03FA01G03FB05
Related LinksKEGG